Time profiles: half-life vs onset vs duration (with examples from the Database)

Abstract "Half-life", "onset" and "duration" are used as if they were the same thing - and that's where misinterpretations are born: unrealistic expectations, faulty readings of results and weak inferences ("it doesn't seem to work", "it lasts less", "it didn't hit"). In this article, we separate the three times with operational definitions, explain why they differ (even when the substance is the same) and apply the logic to real profiles (incretins and pulsatile vs continuous signalling). At the end, you get an auditable table, a mini decision flowchart and internal links to validation and Database profiles.

---

1) Definitions (short, but error-proof)

Half-life (t½)

Definition: time for the plasma concentration to drop 50% (under a specific model).

What it solves: decay rate, accumulation and time to steady-state; helps estimate cadence.

Which does NOT solve it: onset of effect, functional duration, or "how long it works".

Onset

Definition: time to first detectable effect on the chosen endpoint (symptom, biomarker, performance, behaviour).

What it solves: when it makes sense to measure and interpret the "beginning".

Which does NOT solve it: how long the effect lasts (that's duration).

Duration

Definition: time in which the effect remains above a functional threshold (the "useful window").

What it solves: utility window and consistency of the effect on your endpoint.

Which does NOT solve it: identity/purity (COA), nor process compatibility/stability.

---

2) Why these three tenses don't match (even when the compound is "the same")

There are four main reasons for the disagreement:

1. Concentration ≠ effectThe effect depends on the receptor, signalling and downstream cascades. There may be a delay (latency) due to indirect mechanisms.
2. Threshold changes everythingduration depends on the chosen threshold. If you change the threshold, you change the duration (even with the same plasma curve).
3. ROA (route) changes profileSlow absorption can smooth out peaks and lengthen the perceived window (without "changing" the molecule).
4. Process/stabilitycold chain, temperature variation, solvent and technical consistency alter real bioavailability and repeatability.

3) Key Terms (shortcuts to the Lexicon)

These terms are the "nodes" of your graph: they define how you interpret timing, useful window and why two profiles with the same half-life can produce different effects.

---

4) Practical examples (how the Database reduces "invention")

Example A - Incretines: long t½, variable functional onset

In incretin/metabolic agonists, the half-life can be long, but the functional onset (appetite, GI, glycaemia) varies by:

• endpoint (appetite vs glycaemia vs weight);
• adaptation (GI tolerance, behavioural adjustments);
• individual differences in the context (diet, timetables, sleep).

The result: two people with the same t½ can report different onset and perceived duration - because the functional clock is different.

Example B - Pulsatile vs continuous: the "receiver's clock"

Some biological axes are naturally pulsatile; others tolerate continuous presence better. Typical consequences:

• Pulsatingonset can be fast, but the useful window can appear "in waves".
• ContinuousThe onset may seem more gradual, but the functional duration is long - with a risk of desensitisation if the signal is "always on".

---

5) Auditable table (S157) - one common error per row

---

6) Mini-flowchart (quick decision without noise)

1. The onset "doesn't happen"? → validate endpoint and measurement timing; then ROA/absorption; finally stability (cold chain, temperature variations, consistency).
2. Has the duration "shortened" over time? → considers desensitisation (continuous signal) and/or silent degradation (storage, thermal stress).
3. Are the results "random"? → audits concentration (mg/mL) and scale (U-100), and confirms process repeatability with Lab Tools.
4. Does the profile "look good on paper" but fail in practice? → separates document from evidence: passes through COA Auditor and validates identity/purity/report.

7) Related Database Profiles (6 internal shortcuts)

Profiles to see the theory applied to real pages in the Database (metabolic + "pulses" + temporal contrast):

Safety Note (S157): Educational content. Does not constitute medical advice. For risk reduction principles, please consult Information Use Policy and always validates material, documents and process consistency.